- GlobeNewswire•2 days ago
TEL-AVIV, Israel, Sept. 27, 2016-- RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small ...
- GlobeNewswire•8 days ago
PRESS RELEASE TiGenix Appoints Dr. June Almenoff to its Board of Directors Leuven (BELGIUM) - September 22, 2016, 07:00h CET - TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company ...
- GlobeNewswire•8 days agoRedHill Biopharma and IntelGenx Announce RIZAPORT® Commercialization Term Sheet with Pharmatronic Co. for Korea
RIZAPORT ® (5 mg and 10 mg) was granted marketing approval in Germany under the European Decentralized Procedure (DCP) This binding term sheet for the license of RIZAPORT ® in South Korea follows a recent ...
RedHill Biopharma Ltd. (RDHL)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||14.37 x 100|
|Ask||14.52 x 100|
|Day's Range||14.25 - 14.76|
|52wk Range||8.10 - 16.54|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-8.16|
|Avg Vol (3m)||34,925|
|Dividend & Yield||N/A (N/A)|